{
  "id": 1405,
  "text": "One previously published meta-analysis1242 showed also no differences between high dose-rate and low dose-rate intracavity brachytherapy in the survival and complication rates.It should be noted that four1238-1241 of the five RCTs1238-1241,1243 included in this meta-analysis1242 were also included in the meta-analysis published by Liu et al.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: One previously published meta-analysis1242 showed also no differences between high dose-rate and low dose-rate intracavity brachytherapy in the survival and complication rates.It should be noted that four1238-1241 of the five RCTs1238-1241,1243 included in this meta-analysis1242 were also included in the meta-analysis published by Liu et al.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "该文章提到的荟萃分析结果表明，在宫颈癌治疗中，高剂量率与低剂量率腔内近距离放射治疗在生存率和并发症发生率方面没有显著差异。这说明在选择治疗方案时，两种剂量率的近距离放射治疗可能具有相似的效果。宫颈癌患者在治疗方案的选择上可以考虑其他因素，如治疗方式的可行性、患者个体状况，以及医生的建议等。总的来说，这为宫颈癌的治疗提供了多种选择，同时保证了治疗的有效性和安全性。",
  "query": "**SKIP**",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: **SKIP**\n\n<reference text>: One previously published meta-analysis1242 showed also no differences between high dose-rate and low dose-rate intracavity brachytherapy in the survival and complication rates.It should be noted that four1238-1241 of the five RCTs1238-1241,1243 included in this meta-analysis1242 were also included in the meta-analysis published by Liu et al.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "该文章提到的荟萃分析结果表明，在宫颈癌治疗中，高剂量率与低剂量率腔内近距离放射治疗在生存率和并发症发生率方面没有显著差异。这说明在选择治疗方案时，两种剂量率的近距离放射治疗可能具有相似的效果。宫颈癌患者在治疗方案的选择上可以考虑其他因素，如治疗方式的可行性、患者个体状况，以及医生的建议等。总的来说，这为宫颈癌的治疗提供了多种选择，同时保证了治疗的有效性和安全性。"
}